Zemdri (plazomicin) Injection
Product Images NDC 69097-820

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zemdri (plazomicin) (NDC 69097-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zemdri 01)

Chemical structure of plazomicin, the active ingredient in Zemdri injection. The structure includes multiple rings and functional groups, with an annotation indicating the presence of 2.5 molecules of sulfuric acid (H2SO4).*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

The packaging label for Zemdri (plazomicin) Injection displays a 500 mg/10 mL (50 mg/mL) intravenous injection in 10 (10 mL) single-dose vials. Label includes dosage form, concentration, and instructions to dilute before use. Manufactured by Cipla USA Inc., with NDC 69097-820-96. Storage instructions: refrigerate at 2°C to 8°C (36°F to 46°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.